974 related articles for article (PubMed ID: 32787942)
1. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
[TBL] [Abstract][Full Text] [Related]
2. Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China.
Liu Q; Li W; Du X; Li W; Zhong T; Tang Y; Feng Y; Tao C; Xie Y
PLoS One; 2015; 10(6):e0130701. PubMed ID: 26083415
[TBL] [Abstract][Full Text] [Related]
3. Clinical Presentations and Outcomes of Post-Operative Central Nervous System Infection Caused by Multi-Drug-Resistant/Extensively Drug-Resistant
Liang W; Yuan-Run Z; Min Y
Surg Infect (Larchmt); 2019 Sep; 20(6):460-464. PubMed ID: 30942663
[No Abstract] [Full Text] [Related]
4. Infection with multidrug-resistant gram-negative bacteria in a pediatric oncology intensive care unit: risk factors and outcomes.
Costa Pde O; Atta EH; Silva AR
J Pediatr (Rio J); 2015; 91(5):435-41. PubMed ID: 26057184
[TBL] [Abstract][Full Text] [Related]
5. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality.
Li YJ; Pan CZ; Fang CQ; Zhao ZX; Chen HL; Guo PH; Zhao ZW
BMC Infect Dis; 2017 May; 17(1):371. PubMed ID: 28558660
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.
Mekonnen H; Seid A; Molla Fenta G; Gebrecherkos T
PLoS One; 2021; 16(11):e0257272. PubMed ID: 34780494
[TBL] [Abstract][Full Text] [Related]
7. Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia.
Freire MP; de Oliveira Garcia D; Garcia CP; Campagnari Bueno MF; Camargo CH; Kono Magri ASG; Francisco GR; Reghini R; Vieira MF; Ibrahim KY; Rossi F; Hajjar L; Levin AS; Hoff PM; Pierrotti LC; Abdala E
Clin Microbiol Infect; 2016 Apr; 22(4):352-358. PubMed ID: 26711434
[TBL] [Abstract][Full Text] [Related]
8. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii.
Huang H; Chen B; Liu G; Ran J; Lian X; Huang X; Wang N; Huang Z
BMC Infect Dis; 2018 Jan; 18(1):11. PubMed ID: 29304746
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital.
Zhou H; Yao Y; Zhu B; Ren D; Yang Q; Fu Y; Yu Y; Zhou J
Medicine (Baltimore); 2019 Mar; 98(13):e14937. PubMed ID: 30921191
[TBL] [Abstract][Full Text] [Related]
10. Multidrug and carbapenem-resistant Acinetobacter baumannii infections: Factors associated with mortality.
Hernández-Torres A; García-Vázquez E; Gómez J; Canteras M; Ruiz J; Yagüe G
Med Clin (Barc); 2012 May; 138(15):650-5. PubMed ID: 22093403
[TBL] [Abstract][Full Text] [Related]
11. Clonal dissemination of extensively drug-resistant Acinetobacter baumannii producing an OXA-23 β-lactamase at a teaching hospital in Shanghai, China.
Li Y; Guo Q; Wang P; Zhu D; Ye X; Wu S; Wang M
J Microbiol Immunol Infect; 2015 Feb; 48(1):101-8. PubMed ID: 24863499
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR
Pan S; Huang X; Wang Y; Li L; Zhao C; Yao Z; Cui W; Zhang G
Antimicrob Resist Infect Control; 2018; 7():8. PubMed ID: 29387342
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.
Lee NY; Lee HC; Ko NY; Chang CM; Shih HI; Wu CJ; Ko WC
Infect Control Hosp Epidemiol; 2007 Jun; 28(6):713-9. PubMed ID: 17520546
[TBL] [Abstract][Full Text] [Related]
14. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.
Chen CT; Wang YC; Kuo SC; Shih FH; Chen TL; How CK; Yang YS; Lee YT
J Microbiol Immunol Infect; 2018 Oct; 51(5):629-635. PubMed ID: 28701266
[TBL] [Abstract][Full Text] [Related]
15. A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
Ng TM; Teng CB; Lye DC; Apisarnthanarak A
Infect Control Hosp Epidemiol; 2014 Jan; 35(1):49-55. PubMed ID: 24334798
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.
Munoz-Price LS; Zembower T; Penugonda S; Schreckenberger P; Lavin MA; Welbel S; Vais D; Baig M; Mohapatra S; Quinn JP; Weinstein RA
Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1057-62. PubMed ID: 20715975
[TBL] [Abstract][Full Text] [Related]
17. [Acinetobacter baumannii: an important pathogen with multidrug resistance in newborns].
Celik IH; Demirel G; Tatar Aksoy H; Saygan S; Canpolat FE; Uras N; Oğuz SS; Erdeve O; Dilmen U
Mikrobiyol Bul; 2011 Oct; 45(4):716-22. PubMed ID: 22090302
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and outcomes of hospitalized patients with blood infections caused by multidrug-resistant Acinetobacter baumannii complex in a hospital of Northern China.
Guo N; Xue W; Tang D; Ding J; Zhao B
Am J Infect Control; 2016 Apr; 44(4):e37-9. PubMed ID: 26804303
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients.
Trottier V; Namias N; Pust DG; Nuwayhid Z; Manning R; Marttos AC; Dunham MB; Schulman CI; McKenney MG
Surg Infect (Larchmt); 2007 Aug; 8(4):437-43. PubMed ID: 17883360
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors and Outcomes Associated with Multidrug-Resistant Acinetobacter baumannii upon Intensive Care Unit Admission.
Blanco N; Harris AD; Rock C; Johnson JK; Pineles L; Bonomo RA; Srinivasan A; Pettigrew MM; Thom KA;
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29133567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
